Global Afatinib Maleate Tablets Market Growth (Status and Outlook) 2026-2032

July 2026 | 81 pages | ID: G5F02E298ADCEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Afatinib Maleate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Afatinib Maleate Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Afatinib Maleate Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Afatinib Maleate Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Afatinib Maleate Tablets players cover Boehringer Ingelheim International GmbH, Kelun?Kazpharm, Hansoh Pharmaceuticak, Qilu Pharmaceutical, Chia Tai-Tianqing, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Afatinib Maleate Tablets Industry Forecast? looks at past sales and reviews total world Afatinib Maleate Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Afatinib Maleate Tablets sales for 2026 through 2032. With Afatinib Maleate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib Maleate Tablets industry.

This Insight Report provides a comprehensive analysis of the global Afatinib Maleate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Afatinib Maleate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Afatinib Maleate Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib Maleate Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib Maleate Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib Maleate Tablets market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • 20mg
  • 30mg
  • 40mg
  • 50mg
Segmentation by Application:
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Boehringer Ingelheim International GmbH
  • Kelun?Kazpharm
  • Hansoh Pharmaceuticak
  • Qilu Pharmaceutical
  • Chia Tai-Tianqing
  • Yangtze River Pharm
  • Beacon Pharmaceuticals
  • Qingfeng Medicine Group
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Afatinib Maleate Tablets Market Size (2021-2032)
  2.1.2 Afatinib Maleate Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Afatinib Maleate Tablets by Country/Region (2021, 2025 & 2032)
2.2 Afatinib Maleate Tablets Segment by Type
  2.2.1 20mg
  2.2.2 30mg
  2.2.3 40mg
  2.2.4 50mg
  2.2.5 Afatinib Maleate Tablets Market Size by Type
    2.2.5.1 Afatinib Maleate Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Afatinib Maleate Tablets Market Size Market Share by Type (2021-2026)
2.3 Afatinib Maleate Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Afatinib Maleate Tablets Market Size by Application
    2.3.4.1 Afatinib Maleate Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Afatinib Maleate Tablets Market Size Market Share by Application (2021-2026)

3 AFATINIB MALEATE TABLETS MARKET SIZE BY PLAYER

3.1 Afatinib Maleate Tablets Market Size Market Share by Player
  3.1.1 Global Afatinib Maleate Tablets Revenue by Player (2021-2026)
  3.1.2 Global Afatinib Maleate Tablets Revenue Market Share by Player (2021-2026)
3.2 Global Afatinib Maleate Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AFATINIB MALEATE TABLETS BY REGION

4.1 Afatinib Maleate Tablets Market Size by Region (2021-2026)
4.2 Global Afatinib Maleate Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Afatinib Maleate Tablets Market Size Growth (2021-2026)
4.4 APAC Afatinib Maleate Tablets Market Size Growth (2021-2026)
4.5 Europe Afatinib Maleate Tablets Market Size Growth (2021-2026)
4.6 Middle East & Africa Afatinib Maleate Tablets Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Afatinib Maleate Tablets Market Size by Country (2021-2026)
5.2 Americas Afatinib Maleate Tablets Market Size by Type (2021-2026)
5.3 Americas Afatinib Maleate Tablets Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Afatinib Maleate Tablets Market Size by Region (2021-2026)
6.2 APAC Afatinib Maleate Tablets Market Size by Type (2021-2026)
6.3 APAC Afatinib Maleate Tablets Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Afatinib Maleate Tablets Market Size by Country (2021-2026)
7.2 Europe Afatinib Maleate Tablets Market Size by Type (2021-2026)
7.3 Europe Afatinib Maleate Tablets Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Afatinib Maleate Tablets by Region (2021-2026)
8.2 Middle East & Africa Afatinib Maleate Tablets Market Size by Type (2021-2026)
8.3 Middle East & Africa Afatinib Maleate Tablets Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL AFATINIB MALEATE TABLETS MARKET FORECAST

10.1 Global Afatinib Maleate Tablets Forecast by Region (2027-2032)
  10.1.1 Global Afatinib Maleate Tablets Forecast by Region (2027-2032)
  10.1.2 Americas Afatinib Maleate Tablets Forecast
  10.1.3 APAC Afatinib Maleate Tablets Forecast
  10.1.4 Europe Afatinib Maleate Tablets Forecast
  10.1.5 Middle East & Africa Afatinib Maleate Tablets Forecast
10.2 Americas Afatinib Maleate Tablets Forecast by Country (2027-2032)
  10.2.1 United States Market Afatinib Maleate Tablets Forecast
  10.2.2 Canada Market Afatinib Maleate Tablets Forecast
  10.2.3 Mexico Market Afatinib Maleate Tablets Forecast
  10.2.4 Brazil Market Afatinib Maleate Tablets Forecast
10.3 APAC Afatinib Maleate Tablets Forecast by Region (2027-2032)
  10.3.1 China Afatinib Maleate Tablets Market Forecast
  10.3.2 Japan Market Afatinib Maleate Tablets Forecast
  10.3.3 Korea Market Afatinib Maleate Tablets Forecast
  10.3.4 Southeast Asia Market Afatinib Maleate Tablets Forecast
  10.3.5 India Market Afatinib Maleate Tablets Forecast
  10.3.6 Australia Market Afatinib Maleate Tablets Forecast
10.4 Europe Afatinib Maleate Tablets Forecast by Country (2027-2032)
  10.4.1 Germany Market Afatinib Maleate Tablets Forecast
  10.4.2 France Market Afatinib Maleate Tablets Forecast
  10.4.3 UK Market Afatinib Maleate Tablets Forecast
  10.4.4 Italy Market Afatinib Maleate Tablets Forecast
  10.4.5 Russia Market Afatinib Maleate Tablets Forecast
10.5 Middle East & Africa Afatinib Maleate Tablets Forecast by Region (2027-2032)
  10.5.1 Egypt Market Afatinib Maleate Tablets Forecast
  10.5.2 South Africa Market Afatinib Maleate Tablets Forecast
  10.5.3 Israel Market Afatinib Maleate Tablets Forecast
  10.5.4 Turkey Market Afatinib Maleate Tablets Forecast
10.6 Global Afatinib Maleate Tablets Forecast by Type (2027-2032)
10.7 Global Afatinib Maleate Tablets Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Afatinib Maleate Tablets Forecast

11 KEY PLAYERS ANALYSIS

11.1 Boehringer Ingelheim International GmbH
  11.1.1 Boehringer Ingelheim International GmbH Company Information
  11.1.2 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Offered
  11.1.3 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Boehringer Ingelheim International GmbH Main Business Overview
  11.1.5 Boehringer Ingelheim International GmbH Latest Developments
11.2 Kelun?Kazpharm
  11.2.1 Kelun?Kazpharm Company Information
  11.2.2 Kelun?Kazpharm Afatinib Maleate Tablets Product Offered
  11.2.3 Kelun?Kazpharm Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Kelun?Kazpharm Main Business Overview
  11.2.5 Kelun?Kazpharm Latest Developments
11.3 Hansoh Pharmaceuticak
  11.3.1 Hansoh Pharmaceuticak Company Information
  11.3.2 Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Offered
  11.3.3 Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Hansoh Pharmaceuticak Main Business Overview
  11.3.5 Hansoh Pharmaceuticak Latest Developments
11.4 Qilu Pharmaceutical
  11.4.1 Qilu Pharmaceutical Company Information
  11.4.2 Qilu Pharmaceutical Afatinib Maleate Tablets Product Offered
  11.4.3 Qilu Pharmaceutical Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Qilu Pharmaceutical Main Business Overview
  11.4.5 Qilu Pharmaceutical Latest Developments
11.5 Chia Tai-Tianqing
  11.5.1 Chia Tai-Tianqing Company Information
  11.5.2 Chia Tai-Tianqing Afatinib Maleate Tablets Product Offered
  11.5.3 Chia Tai-Tianqing Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Chia Tai-Tianqing Main Business Overview
  11.5.5 Chia Tai-Tianqing Latest Developments
11.6 Yangtze River Pharm
  11.6.1 Yangtze River Pharm Company Information
  11.6.2 Yangtze River Pharm Afatinib Maleate Tablets Product Offered
  11.6.3 Yangtze River Pharm Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Yangtze River Pharm Main Business Overview
  11.6.5 Yangtze River Pharm Latest Developments
11.7 Beacon Pharmaceuticals
  11.7.1 Beacon Pharmaceuticals Company Information
  11.7.2 Beacon Pharmaceuticals Afatinib Maleate Tablets Product Offered
  11.7.3 Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Beacon Pharmaceuticals Main Business Overview
  11.7.5 Beacon Pharmaceuticals Latest Developments
11.8 Qingfeng Medicine Group
  11.8.1 Qingfeng Medicine Group Company Information
  11.8.2 Qingfeng Medicine Group Afatinib Maleate Tablets Product Offered
  11.8.3 Qingfeng Medicine Group Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Qingfeng Medicine Group Main Business Overview
  11.8.5 Qingfeng Medicine Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Afatinib Maleate Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Afatinib Maleate Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 20mg
Table 4. Major Players of 30mg
Table 5. Major Players of 40mg
Table 6. Major Players of 50mg
Table 7. Afatinib Maleate Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Afatinib Maleate Tablets Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Afatinib Maleate Tablets Market Size Market Share by Type (2021-2026)
Table 10. Afatinib Maleate Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Afatinib Maleate Tablets Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Afatinib Maleate Tablets Market Size Market Share by Application (2021-2026)
Table 13. Global Afatinib Maleate Tablets Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Afatinib Maleate Tablets Revenue Market Share by Player (2021-2026)
Table 15. Afatinib Maleate Tablets Key Players Head office and Products Offered
Table 16. Afatinib Maleate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Afatinib Maleate Tablets Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Afatinib Maleate Tablets Market Size Market Share by Region (2021-2026)
Table 21. Global Afatinib Maleate Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Afatinib Maleate Tablets Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Afatinib Maleate Tablets Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Afatinib Maleate Tablets Market Size Market Share by Country (2021-2026)
Table 25. Americas Afatinib Maleate Tablets Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Afatinib Maleate Tablets Market Size Market Share by Type (2021-2026)
Table 27. Americas Afatinib Maleate Tablets Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Afatinib Maleate Tablets Market Size Market Share by Application (2021-2026)
Table 29. APAC Afatinib Maleate Tablets Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Afatinib Maleate Tablets Market Size Market Share by Region (2021-2026)
Table 31. APAC Afatinib Maleate Tablets Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Afatinib Maleate Tablets Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Afatinib Maleate Tablets Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Afatinib Maleate Tablets Market Size Market Share by Country (2021-2026)
Table 35. Europe Afatinib Maleate Tablets Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Afatinib Maleate Tablets Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Afatinib Maleate Tablets Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Afatinib Maleate Tablets Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Afatinib Maleate Tablets Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Afatinib Maleate Tablets
Table 41. Key Market Challenges & Risks of Afatinib Maleate Tablets
Table 42. Key Industry Trends of Afatinib Maleate Tablets
Table 43. Global Afatinib Maleate Tablets Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Afatinib Maleate Tablets Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Afatinib Maleate Tablets Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Afatinib Maleate Tablets Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Boehringer Ingelheim International GmbH Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 48. Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Offered
Table 49. Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Boehringer Ingelheim International GmbH Main Business
Table 51. Boehringer Ingelheim International GmbH Latest Developments
Table 52. Kelun?Kazpharm Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 53. Kelun?Kazpharm Afatinib Maleate Tablets Product Offered
Table 54. Kelun?Kazpharm Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Kelun?Kazpharm Main Business
Table 56. Kelun?Kazpharm Latest Developments
Table 57. Hansoh Pharmaceuticak Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 58. Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Offered
Table 59. Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Hansoh Pharmaceuticak Main Business
Table 61. Hansoh Pharmaceuticak Latest Developments
Table 62. Qilu Pharmaceutical Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 63. Qilu Pharmaceutical Afatinib Maleate Tablets Product Offered
Table 64. Qilu Pharmaceutical Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Qilu Pharmaceutical Main Business
Table 66. Qilu Pharmaceutical Latest Developments
Table 67. Chia Tai-Tianqing Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 68. Chia Tai-Tianqing Afatinib Maleate Tablets Product Offered
Table 69. Chia Tai-Tianqing Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Chia Tai-Tianqing Main Business
Table 71. Chia Tai-Tianqing Latest Developments
Table 72. Yangtze River Pharm Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 73. Yangtze River Pharm Afatinib Maleate Tablets Product Offered
Table 74. Yangtze River Pharm Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Yangtze River Pharm Main Business
Table 76. Yangtze River Pharm Latest Developments
Table 77. Beacon Pharmaceuticals Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 78. Beacon Pharmaceuticals Afatinib Maleate Tablets Product Offered
Table 79. Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Beacon Pharmaceuticals Main Business
Table 81. Beacon Pharmaceuticals Latest Developments
Table 82. Qingfeng Medicine Group Details, Company Type, Afatinib Maleate Tablets Area Served and Its Competitors
Table 83. Qingfeng Medicine Group Afatinib Maleate Tablets Product Offered
Table 84. Qingfeng Medicine Group Afatinib Maleate Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Qingfeng Medicine Group Main Business
Table 86. Qingfeng Medicine Group Latest Developments

LIST OF FIGURES

Figure 1. Afatinib Maleate Tablets Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Afatinib Maleate Tablets Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Afatinib Maleate Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Afatinib Maleate Tablets Sales Market Share by Country/Region (2025)
Figure 8. Afatinib Maleate Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Afatinib Maleate Tablets Market Size Market Share by Type in 2025
Figure 10. Afatinib Maleate Tablets in Hospital
Figure 11. Global Afatinib Maleate Tablets Market: Hospital (2021-2026) & ($ millions)
Figure 12. Afatinib Maleate Tablets in Clinic
Figure 13. Global Afatinib Maleate Tablets Market: Clinic (2021-2026) & ($ millions)
Figure 14. Afatinib Maleate Tablets in Others
Figure 15. Global Afatinib Maleate Tablets Market: Others (2021-2026) & ($ millions)
Figure 16. Global Afatinib Maleate Tablets Market Size Market Share by Application in 2025
Figure 17. Global Afatinib Maleate Tablets Revenue Market Share by Player in 2025
Figure 18. Global Afatinib Maleate Tablets Market Size Market Share by Region (2021-2026)
Figure 19. Americas Afatinib Maleate Tablets Market Size 2021-2026 ($ millions)
Figure 20. APAC Afatinib Maleate Tablets Market Size 2021-2026 ($ millions)
Figure 21. Europe Afatinib Maleate Tablets Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Afatinib Maleate Tablets Market Size 2021-2026 ($ millions)
Figure 23. Americas Afatinib Maleate Tablets Value Market Share by Country in 2025
Figure 24. United States Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Afatinib Maleate Tablets Market Size Market Share by Region in 2025
Figure 29. APAC Afatinib Maleate Tablets Market Size Market Share by Type (2021-2026)
Figure 30. APAC Afatinib Maleate Tablets Market Size Market Share by Application (2021-2026)
Figure 31. China Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 35. India Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Afatinib Maleate Tablets Market Size Market Share by Country in 2025
Figure 38. Europe Afatinib Maleate Tablets Market Size Market Share by Type (2021-2026)
Figure 39. Europe Afatinib Maleate Tablets Market Size Market Share by Application (2021-2026)
Figure 40. Germany Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 41. France Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Afatinib Maleate Tablets Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Afatinib Maleate Tablets Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Afatinib Maleate Tablets Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Afatinib Maleate Tablets Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 54. APAC Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 55. Europe Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 57. United States Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 58. Canada Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 59. Mexico Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 60. Brazil Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 61. China Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 62. Japan Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 63. Korea Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 65. India Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 66. Australia Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 67. Germany Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 68. France Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 69. UK Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 70. Italy Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 71. Russia Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 72. Egypt Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 73. South Africa Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 74. Israel Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 75. Turkey Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)
Figure 76. Global Afatinib Maleate Tablets Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Afatinib Maleate Tablets Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Afatinib Maleate Tablets Market Size 2027-2032 ($ millions)


More Publications